This is the current new epidemic. The monkeypox has now arrived in France with seven proven cases of the disease, according to the Minister of Health, Brigitte Bourguignon. At the same time, the Swiss pharmaceutical giant Roche announced on Wednesday May 25 that it had developed tPCR tests for the detection of the virus of the monkeypox.
Director of the Diagnostics Division of Roche welcomed this achievement in a press release. Following the many cases reported worldwide which have recently caused concern, the director is pleased that the Roche laboratory has “very quickly developed a new series of tests for the detection of the simian pox virus and monitoring its spread.”
For the moment, this type of PCR test is not intended for the general public but has been developed to to help scientific research in most countries of the world. A first kit detects orthopoxviruses, including monkeypox viruses (monkey pox), a second specifically detects monkeypox viruses, while a third kit makes it possible to detect orthopoxviruses while specifying whether a monkeypox virus monkeypox is present or not.
According to the World Health Organization (WHO), PCR tests are preferred for detecting disease because antigenic tests cannot determine whether it is the smallpox virus monkey or other related viruses.